China Vaccine Maker CanSino to Offer Pakistan 20 Million Doses
- CanSino about to release efficacy data from final stage trials
- Pakistan is among lower-income nations behind in vaccine race
This article is for subscribers only.
CanSino Biologics Inc. has offered 20 million shots to Pakistan as it gets ready to release efficacy results “in a few days” from phase III trials that have recently been completed in the South Asian nation, according to its local partner.
The Chinese maker of the single-shot vaccine will be giving Pakistan preferential access and pricing, said Hasan Abbas Zaheer, technical adviser at AJM Pharma Pvt., the local partner. It has already applied with Pakistan’s drug regulator to get approval.